Biodesix, Inc., a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which Biodesix will conduct the development, clinical validation, and ...

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Bio-Rad ...

ISLAMABAD: Contractors of the multi-million-dollar Islamabad–West Grid Station (IWGS) project, funded by the World Bank, have served notice of suspension of work due to alleged non-performance of ...

Bluebird bio has molted to reveal a new—or new-ish, at least—brand identity. After a busy summer that saw the drugmaker sell itself to a pair of private equity firms, go private and install new ...

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Bio-Rad Laboratories, Inc. stands amongst them. Bio-Rad Laboratories, Inc. (NYSE:BIO), a global ...

In 2025, what might have been seen as signs of recovery at Trinidad and Tobago’s National Gas Company (NGC) are marred by decisions that have reignited concerns about leadership, priorities, and ...

Borderlands 4’s Bio-Bulkhead is one of the first bosses you fight in the game and the grappling hook is fundamental to get to the boss. Unlike anything you have faced so far in the game, Bio-Bulkhead ...

HAVE TO DO WITH AN ALLEGHENY COUNTY LIBRARY CARD? YEAH, WELL, ANDREW, IT’S A NEW CHAPTER FOR THE RAD PROGRAM. COUNTY EXECUTIVE SARA INNAMORATO SAYING THE RAD PROGRAM IS NO LONGER ABOUT A DAY OR SEASON ...

All products featured on WIRED are independently selected by our editors. However, when you buy something through our retail links, we may earn an affiliate commission. Needs more color options. Fat ...

Bio-Rad Laboratories Inc. reported a strong performance in the second quarter of 2025, with earnings per share (EPS) of $2.61, surpassing the forecast of $1.73 by 50.87%. Revenue for the quarter ...

Thank you for standing by. My name is Gill, and I will be your operator for today's call. At this time, I would like to welcome each and every one of you to the Bio-Rad Second Quarter 2025 Results ...